Aerovate furnishes corporate presentation with no new material facts disclosed

Jade Biosciences, Inc.

Corporate presentation filed as Exhibit 99.1; no updated financial or clinical data provided.
Presentation reiterates focus on AV-101 for pulmonary arterial hypertension.
Filing is routine Regulation FD disclosure; no guidance or milestone changes announced.

item 7.01 item 9.01

Jade Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001798749-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.